{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:02:25Z","timestamp":1787770945719,"version":"build-2784847793"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T00:00:00Z","timestamp":1689033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T00:00:00Z","timestamp":1689033600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Epstein\u2013Barr virus (EBV)-associated gastric cancer exhibits distinct clinicopathologic characteristics, showing a good response to immune checkpoint inhibitors and a favorable prognosis. However, gastric cancer comprising distinct EBV-positive and -negative components in a single mass have been rarely reported, and their detailed genetic characteristics have not yet been investigated. Therefore, we reported the case of gastric cancer exhibiting distinct EBV-positive and -negative areas and further investigated its genetic characteristics.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentations<\/jats:title>\n                <jats:p>A 70-year-old man underwent distal gastrectomy for gastric cancer, which was detected during a routine health check-up. EBV-encoded RNA in situ hybridization revealed distinct EBV-positive and -negative components at each other\u2019s borders, morphologically consistent with collision tumor. We separately sequenced EBV-positive and -negative tumor areas through whole exome sequencing (WES) with matched normal tissue. Remarkably, both EBV-positive and -negative areas shared pathogenic mutations of <jats:italic>ARID1A<\/jats:italic>, <jats:italic>KCNJ2<\/jats:italic>, and <jats:italic>RRAS2<\/jats:italic>. Furthermore, they shared 92 somatic single nucleotide variants and small insertion or deletion mutations, of which 32.7% and 24.5% are EBV-positive and -negative tumor components, respectively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>WES results suggested that gastric cancer with distinct EBV-positive and -negative tumor components, formerly categorized as a collision tumor, can be clonally related. EBV-negative tumor component might be associated with loss of EBV during tumor progression.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13000-023-01363-3","type":"journal-article","created":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T11:02:00Z","timestamp":1689073320000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Gastric cancer with distinct Epstein\u2013Barr virus-positive and -negative tumor components and their whole exome sequencing result: a case Report"],"prefix":"10.1186","volume":"18","author":[{"given":"Ki Bum","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An Na","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moonsik","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,11]]},"reference":[{"key":"1363_CR1","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.canlet.2020.09.019","volume":"495","author":"J Yang","year":"2020","unstructured":"Yang J, et al. Epstein-Barr virus-associated gastric cancer: a distinct subtype. Cancer Lett. 2020;495:191\u20139.","journal-title":"Cancer Lett"},{"issue":"2","key":"1363_CR2","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1007\/s10120-014-0376-9","volume":"18","author":"N Cheng","year":"2015","unstructured":"Cheng N, et al. Is gastric lymphoepithelioma-like carcinoma a special subtype of EBV-associated gastric carcinoma? New insight based on clinicopathological features and EBV genome polymorphisms. Gastric Cancer. 2015;18(2):246\u201355.","journal-title":"Gastric Cancer"},{"key":"1363_CR3","doi-asserted-by":"publisher","first-page":"583463","DOI":"10.3389\/fonc.2020.583463","volume":"10","author":"K Sun","year":"2020","unstructured":"Sun K, et al. EBV-Positive gastric Cancer: current knowledge and future perspectives. Front Oncol. 2020;10:583463.","journal-title":"Front Oncol"},{"issue":"7","key":"1363_CR4","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/s41575-022-00591-0","volume":"19","author":"Y Zavros","year":"2022","unstructured":"Zavros Y, Merchant JL. The immune microenvironment in gastric adenocarcinoma. Nat Rev Gastroenterol Hepatol. 2022;19(7):451\u201367.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"7517","key":"1363_CR5","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/nature13480","volume":"513","author":"Cancer Genome Atlas Research","year":"2014","unstructured":"Cancer Genome Atlas Research. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513(7517):202\u20139.","journal-title":"Nature"},{"issue":"1","key":"1363_CR6","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12876-021-01683-y","volume":"21","author":"K Miyabe","year":"2021","unstructured":"Miyabe K, et al. Collision of Epstein-Barr virus-positive and -negative gastric cancer, diagnosed by molecular analysis: a case report. BMC Gastroenterol. 2021;21(1):97.","journal-title":"BMC Gastroenterol"},{"issue":"9","key":"1363_CR7","first-page":"11766","volume":"8","author":"I Matsuda","year":"2015","unstructured":"Matsuda I, et al. A case of gastric cancer with heterogeneous components of EB virus (+)\/TP53 (+) and EB virus (-)\/TP53 (-). Int J Clin Exp Pathol. 2015;8(9):11766\u201371.","journal-title":"Int J Clin Exp Pathol"},{"issue":"12","key":"1363_CR8","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.3919\/jjsa.76.2971","volume":"76","author":"H Aoyama","year":"2015","unstructured":"Aoyama H, et al. Collision tumor involving gastric carcinoma with lymphoid stroma and moderately differentiated adenocarcinoma. J Japan Surg Assoc. 2015;76(12):2971\u20136.","journal-title":"J Japan Surg Assoc"},{"issue":"6","key":"1363_CR9","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.3919\/jjsa.71.1513","volume":"71","author":"A Okada","year":"2010","unstructured":"Okada A, et al. Gastric collision tumor of adenocarcinoma and Epstein\u2013Barr virus\u2013related carcinoma\u2013a case report\u2013. J Japan Surg Assoc. 2010;71(6):1513\u20137.","journal-title":"J Japan Surg Assoc"},{"issue":"6","key":"1363_CR10","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1078\/0344-0338-00052","volume":"197","author":"MS Chang","year":"2001","unstructured":"Chang MS, et al. Clinicopathologic characteristics of Epstein-Barr virus-incorporated gastric cancers in Korea. Pathol Res Pract. 2001;197(6):395\u2013400.","journal-title":"Pathol Res Pract"},{"issue":"5","key":"1363_CR11","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/pin.12060","volume":"63","author":"SH Lee","year":"2013","unstructured":"Lee SH, et al. Genetic alteration and immunohistochemical staining patterns of ovarian high-grade serous adenocarcinoma with special emphasis on p53 immnnostaining pattern. Pathol Int. 2013;63(5):252\u20139.","journal-title":"Pathol Int"},{"issue":"9","key":"1363_CR12","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1038\/modpathol.2011.85","volume":"24","author":"A Yemelyanova","year":"2011","unstructured":"Yemelyanova A, et al. Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysis. Mod Pathol. 2011;24(9):1248\u201353.","journal-title":"Mod Pathol"},{"issue":"2","key":"1363_CR13","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s41379-021-00872-0","volume":"35","author":"M Kim","year":"2022","unstructured":"Kim M, et al. Genomic characteristics of invasive mucinous adenocarcinoma of the lung with multiple pulmonary sites of involvement. Mod Pathol. 2022;35(2):202\u20139.","journal-title":"Mod Pathol"},{"issue":"7793","key":"1363_CR14","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41586-020-1943-3","volume":"578","author":"LB Alexandrov","year":"2020","unstructured":"Alexandrov LB, et al. The repertoire of mutational signatures in human cancer. Nature. 2020;578(7793):94\u2013101.","journal-title":"Nature"},{"key":"1363_CR15","doi-asserted-by":"publisher","first-page":"154108","DOI":"10.1016\/j.prp.2022.154108","volume":"238","author":"HN Kim","year":"2022","unstructured":"Kim HN, Ahn S, Kim KM. Gastric cancer with Epstein-Barr virus heterogeneity: evaluation of the frequency, clinicopathologic features, and genomic profiles. Pathol Res Pract. 2022;238:154108.","journal-title":"Pathol Res Pract"},{"issue":"5","key":"1363_CR16","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1093\/annonc\/mdx047","volume":"28","author":"C B\u00f6ger","year":"2017","unstructured":"B\u00f6ger C, et al. Epstein-Barr virus-associated gastric cancer reveals intratumoral heterogeneity of PIK3CA mutations. Ann Oncol. 2017;28(5):1005\u201314.","journal-title":"Ann Oncol"},{"issue":"4","key":"1363_CR17","doi-asserted-by":"publisher","first-page":"273","DOI":"10.5230\/jgc.2022.22.e35","volume":"22","author":"M Kim","year":"2022","unstructured":"Kim M, Seo AN. Molecular Pathology of Gastric Cancer. J Gastric Cancer. 2022;22(4):273\u2013305.","journal-title":"J Gastric Cancer"},{"issue":"8","key":"1363_CR18","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41571-021-00492-2","volume":"18","author":"Y Nakamura","year":"2021","unstructured":"Nakamura Y, et al. Biomarker-targeted therapies for advanced-stage gastric and gastro-oesophageal junction cancers: an emerging paradigm. Nat Rev Clin Oncol. 2021;18(8):473\u201387.","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"1363_CR19","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/path.6067","volume":"260","author":"A Kondo","year":"2023","unstructured":"Kondo A, et al. Loss of viral genome with altered immune microenvironment during tumour progression of Epstein-Barr virus-associated gastric carcinoma. J Pathol. 2023;260(2):124\u201336.","journal-title":"J Pathol"},{"issue":"1","key":"1363_CR20","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13027-022-00469-5","volume":"17","author":"MC Siciliano","year":"2022","unstructured":"Siciliano MC, et al. EBV persistence in gastric cancer cases conventionally classified as EBER-ISH negative. Infect Agent Cancer. 2022;17(1):57.","journal-title":"Infect Agent Cancer"},{"issue":"16","key":"1363_CR21","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1056\/NEJMoa1008433","volume":"363","author":"KC Wiegand","year":"2010","unstructured":"Wiegand KC, et al. ARID1A mutations in endometriosis-associated ovarian carcinomas. N Engl J Med. 2010;363(16):1532\u201343.","journal-title":"N Engl J Med"},{"issue":"3","key":"1363_CR22","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/cjp2.103","volume":"4","author":"S Khalique","year":"2018","unstructured":"Khalique S, et al. Optimised ARID1A immunohistochemistry is an accurate predictor of ARID1A mutational status in gynaecological cancers. J Pathol Clin Res. 2018;4(3):154\u201366.","journal-title":"J Pathol Clin Res"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-023-01363-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-023-01363-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-023-01363-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T11:06:54Z","timestamp":1689073614000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-023-01363-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,11]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1363"],"URL":"https:\/\/doi.org\/10.1186\/s13000-023-01363-3","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,11]]},"assertion":[{"value":"23 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the guidelines of the Declaration of Helsinki and approved by the Institutional Review Board of Kyungpook National University Chilgok Hospital (No. KNUCH 2023-01-008). Informed consent was obtained from the patient for publication of this article and any accompanying images.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"81"}}